Treatment Registry
TR-0286 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Levers · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$296

Medication · Starting price$296

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price

Tirzepatide GLP-1 + GIP Weight Loss Regular price From $296

source

Per month$296Charged today$296
Visit Levers

We earn nothing from this link. Levers has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

States29 states: Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Michigan, Missouri, North Carolina, North Dakota, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, and Wyoming
Cancellation“You may Pause, Cancel, or Modify your plan anytime by logging into your subscription portal.”

Not yet checked: pharmacy, prescriber, membership and consult fee.

Recorded from levers.health. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The FAQ page's states list differs slightly from the semaglutide-program page's own 'Which States Available' list, which additionally omits Kentucky but is otherwise the same 28-state set ('Ships to: AZ, CA, CT, CO, FL, GA, IL, IN, MA, MD, MI, MO, NC, ND, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WY'); the FAQ's 29-state list (which adds KY) was used since it is the page explicitly answering 'What States do you serve?'. The refund-policy page states a refund is available only if requested before the order is processed with the pharmacy ('typically within 1 day'). Site brand name on-page is simply 'Levers' / 'Levers.Health' / 'Levers Health LLC' (footer); the candidate name 'Levers Health' matches the footer legal name.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0286
Readings
1

Related records

What else Levers sells

All Levers programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Levers compounded tirzepatide (TR-0286). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0286

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.